(1)
Miller, MS, C. J.; Dart, MD, R. C.; Katz, MD, MS, N. P.; Webster, MD, FACPM, FASAM, L. R. Insights and Issues from FDA Advisory Committee Meetings on Abuse-Deterrent Opioids. J of Opioid Management 2017, 13, 379-389.